title: Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases.
abstract: OBJECTIVE
  To review the diagnoses after 5 years in patients who were identified within 12 months of the onset of well established and undifferentiated connective tissue diseases (CTD); to examine death rates and disease remissions in these patients.
  
  
  METHODS
  This inception cohort of 410 patients was identified in 10 academic rheumatology practices. They had less than one year of signs and/or symptoms of CTD. Diagnoses of specific well established CTD were made using accepted diagnostic and classification criteria. The diagnoses after 5 years were determined.
  
  
  RESULTS
  Patients with well established CTD tended to remain with the original diagnosis. The progression of unexplained polyarthritis to rheumatoid arthritis occurred infrequently. Ten percent of patients with isolated Raynaud's phenomenon progressed to systemic sclerosis (SSc). The 5 year survival was over 90% in all diagnostic categories, with the exception of SSc, in which it was 64%.
  
  
  CONCLUSIONS
  Patients with a well established CTD usually continued with the same diagnosis. Patients with undifferentiated CTD tended to remain undifferentiated or to remit.
authors.affiliation: Cooperative Systematic Studies of the Rheumatic Diseases Program, the University of Utah School of Medicine, Salt Lake City, USA.
authors.forename: H J
authors.initials: HJ
authors.lastname: Williams
authors.forename: G S
authors.initials: GS
authors.lastname: Alarcón
authors.forename: R
authors.initials: R
authors.lastname: Neuner
authors.forename: V D
authors.initials: VD
authors.lastname: Steen
authors.forename: K
authors.initials: K
authors.lastname: Bulpitt
authors.forename: D O
authors.initials: DO
authors.lastname: Clegg
authors.forename: C M
authors.initials: CM
authors.lastname: Ziminski
authors.forename: M E
authors.initials: ME
authors.lastname: Luggen
authors.forename: R P
authors.initials: RP
authors.lastname: Polisson
authors.forename: R F
authors.initials: RF
authors.lastname: Willkens
authors.forename: C
authors.initials: C
authors.lastname: Yarboro
authors.forename: J
authors.initials: J
authors.lastname: Morgan
authors.forename: M J
authors.initials: MJ
authors.lastname: Egger
authors.forename: J R
authors.initials: JR
authors.lastname: Ward
mesh_terms: D001168:Arthritis / Q000175:diagnosis / Q000401:mortality; D015331:Cohort Studies; D003240:Connective Tissue Diseases / Q000175:diagnosis* / Q000401:mortality; D018450:Disease Progression; D005500:Follow-Up Studies; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000175:diagnosis / Q000401:mortality; D011379:Prognosis; D011928:Raynaud Disease / Q000175:diagnosis / Q000401:mortality; D012216:Rheumatic Diseases / Q000175:diagnosis / Q000401:mortality; D012595:Scleroderma, Systemic / Q000175:diagnosis / Q000401:mortality